2000年至2014年美国结节性淋巴细胞为主型霍奇金淋巴瘤：基于监测、流行病学和最终结果（SEER）数据的最新分析 - Suppr

Suppr

超能文献

Nodular lymphocyte predominant Hodgkin lymphoma in USA between 2000 and 2014: an updated analysis based on the SEER data.

作者信息

Shivarov Velizar, Ivanova Milena

机构信息

Department of Clinical Haematology, Sofiamed University Hospital, Sofia, Bulgaria.

Laboratory of Clinical Immunology, Sofiamed University Hospital, Sofia, Bulgaria.

出版信息

Br J Haematol. 2018 Sep;182(5):727-730. doi: 10.1111/bjh.14861. Epub 2017 Jul 24.

DOI:10.1111/bjh.14861

PMID:28737250

Abstract

摘要

相似文献

Nodular lymphocyte predominant Hodgkin lymphoma in USA between 2000 and 2014: an updated analysis based on the SEER data.

Br J Haematol. 2018 Sep;182(5):727-730. doi: 10.1111/bjh.14861. Epub 2017 Jul 24.

Characteristics and outcomes of patients with nodular lymphocyte-predominant Hodgkin lymphoma versus those with classical Hodgkin lymphoma: a population-based analysis.

Int J Radiat Oncol Biol Phys. 2015 May 1;92(1):76-83. doi: 10.1016/j.ijrobp.2015.02.012. Epub 2015 Mar 14.

A 20-year population-based study on the epidemiology, clinical features, treatment, and outcome of nodular lymphocyte predominant Hodgkin lymphoma.

Ann Hematol. 2016 Feb;95(3):417-23. doi: 10.1007/s00277-015-2578-6. Epub 2016 Jan 5.

Nodular lymphocyte predominant Hodgkin lymphoma in Sweden between 2000 and 2014: an analysis of the Swedish Lymphoma Registry.

Br J Haematol. 2017 May;177(3):449-456. doi: 10.1111/bjh.14567. Epub 2017 Feb 24.

Long-term follow-up of 2 patients treated with Y-rituximab radioimmunotherapy for relapse of nodular lymphocyte-predominant Hodgkin lymphoma.

Eur J Haematol. 2018 Sep;101(3):415-417. doi: 10.1111/ejh.13087. Epub 2018 Jul 4.

Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective study.

Haematologica. 2015 Dec;100(12):1579-86. doi: 10.3324/haematol.2015.133025. Epub 2015 Oct 1.

High-dose chemotherapy and autologous stem cell transplantation for relapsed or refractory nodular lymphocyte predominant Hodgkin lymphoma.

Ann Hematol. 2016 Jan;95(1):49-54. doi: 10.1007/s00277-015-2527-4.

Disparate survival and risk of secondary non-Hodgkin lymphoma in histologic subtypes of Hodgkin lymphoma: a population-based study.

Leuk Lymphoma. 2014 Jul;55(7):1570-7. doi: 10.3109/10428194.2013.847938. Epub 2013 Nov 12.

Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL)-clinicopathological features based on the data of two Hungarian lymphoma centres.

Pathol Oncol Res. 2008 Dec;14(4):411-21. doi: 10.1007/s12253-008-9043-y. Epub 2008 Apr 23.

Nodular lymphocyte predominant Hodgkin lymphoma behaves as a distinct clinical entity with good outcome: evidence from 14-year follow-up in the West of Scotland Cancer Network.

Leuk Lymphoma. 2011 Oct;52(10):1920-8. doi: 10.3109/10428194.2011.584993. Epub 2011 Jun 12.

引用本文的文献

Nodular lymphocyte-predominant Hodgkin lymphoma: advances in disease biology, risk stratification, and treatment.

Haematologica. 2024 Nov 1;109(11):3476-3487. doi: 10.3324/haematol.2024.285903.

Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi.

Hemasphere. 2023 Apr 4;7(4):e837. doi: 10.1097/HS9.0000000000000837. eCollection 2023 Apr.

Transformation and outcome of nodular lymphocyte predominant Hodgkin lymphoma: a Finnish Nationwide population-based study.

Blood Cancer J. 2021 Dec 18;11(12):203. doi: 10.1038/s41408-021-00586-1.

Outcome of limited-stage nodular lymphocyte-predominant Hodgkin lymphoma and the impact of a PET-adapted approach.

Blood Adv. 2021 Sep 28;5(18):3647-3655. doi: 10.1182/bloodadvances.2021004375.

Conditional relative survival among patients with nodular lymphocyte-predominant Hodgkin lymphoma in the Netherlands.

Blood Cancer J. 2021 May 11;11(5):87. doi: 10.1038/s41408-021-00482-8.

Nodular lymphocyte-predominant Hodgkin lymphoma characteristics, management of primary and relapsed/refractory disease and outcome analysis: the first comprehensive report from the Middle East.

BMC Cancer. 2021 Apr 1;21(1):351. doi: 10.1186/s12885-021-08074-2.

Meningeal Relapse of Nodular Lymphocyte Predominant Hodgkin Lymphoma Transformed to T-Cell/Histiocyte-Rich Large B-Cell Lymphoma: A Case Report.

Front Oncol. 2020 Sep 14;10:1745. doi: 10.3389/fonc.2020.01745. eCollection 2020.

Primary therapy and survival among patients with nodular lymphocyte-predominant Hodgkin lymphoma: a population-based analysis in the Netherlands, 1993-2016.

Br J Haematol. 2020 Apr;189(1):117-121. doi: 10.1111/bjh.16290. Epub 2019 Nov 4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验